Latest filing published 07 May 2024 for Oncopeptides AB, €243k.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Stig Anders Jacob Lindberg is a declared insider of Oncopeptides AB, with filings sourced from Finansinspektionen. Between 24 September 2019 and 3 May 2024, the trades on record add up to 6 filings.
On the open market, the record shows 2 purchases worth €196k and 2 sales worth €7.2M. Taken together, the sales exceed the purchases by €7.0M. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
Most recently, on 7 May 2024, the filings show a transaction worth €243k in Oncopeptides AB. The clock since the last published purchase (18 February 2022) now reads 1,710 days. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 1 day. Under the Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations